UniProt ID | SRC_HUMAN | |
---|---|---|
UniProt AC | P12931 | |
Protein Name | Proto-oncogene tyrosine-protein kinase Src | |
Gene Name | SRC | |
Organism | Homo sapiens (Human). | |
Sequence Length | 536 | |
Subcellular Localization | Cell membrane . Mitochondrion inner membrane . Nucleus . Cytoplasm, cytoskeleton . Cytoplasm, perinuclear region . Localizes to focal adhesion sites following integrin engagement. Localization to focal adhesion sites requires myristoylation and the S | |
Protein Description | Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN) (Probable). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN). [PubMed: 21411625 In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1 SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1 (Probable Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors (By similarity Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1] | |
Protein Sequence | MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | N-myristoyl glycine | ------MGSNKSKPK ------CCCCCCCCC | 39.67 | - | |
2 | Myristoylation | ------MGSNKSKPK ------CCCCCCCCC | 39.67 | 7525268 | |
6 | Phosphorylation | --MGSNKSKPKDASQ --CCCCCCCCCCHHH | 59.44 | 20860994 | |
12 | Phosphorylation | KSKPKDASQRRRSLE CCCCCCHHHHHHCCC | 34.06 | 2996780 | |
17 (in isoform 2) | Phosphorylation | - | 34.96 | 21406692 | |
17 | Phosphorylation | DASQRRRSLEPAENV CHHHHHHCCCCCCCC | 34.96 | 19664994 | |
35 | Phosphorylation | GGGAFPASQTPSKPA CCCCCCCCCCCCCCC | 34.52 | 7929427 | |
37 | Phosphorylation | GAFPASQTPSKPASA CCCCCCCCCCCCCCC | 27.34 | 23927012 | |
39 | Phosphorylation | FPASQTPSKPASADG CCCCCCCCCCCCCCC | 55.44 | 23927012 | |
43 | Phosphorylation | QTPSKPASADGHRGP CCCCCCCCCCCCCCC | 35.11 | 23927012 | |
51 | Phosphorylation | ADGHRGPSAAFAPAA CCCCCCCCCCCCCCC | 34.74 | 20071362 | |
62 | Acetylation | APAAAEPKLFGGFNS CCCCCCCCCCCCCCC | 48.21 | 156773 | |
69 | Phosphorylation | KLFGGFNSSDTVTSP CCCCCCCCCCCCCCC | 27.59 | 7929427 | |
70 | Phosphorylation | LFGGFNSSDTVTSPQ CCCCCCCCCCCCCCC | 38.10 | 28176443 | |
72 | Phosphorylation | GGFNSSDTVTSPQRA CCCCCCCCCCCCCCC | 27.86 | 28176443 | |
74 | Phosphorylation | FNSSDTVTSPQRAGP CCCCCCCCCCCCCCC | 36.46 | 7929427 | |
75 | Phosphorylation | NSSDTVTSPQRAGPL CCCCCCCCCCCCCCC | 18.07 | 29255136 | |
93 | Phosphorylation | VTTFVALYDYESRTE CEEEEEEEECCCCCC | 13.52 | - | |
97 | Phosphorylation | VALYDYESRTETDLS EEEEECCCCCCEECC | 37.97 | 1713455 | |
101 | Phosphorylation | DYESRTETDLSFKKG ECCCCCCEECCCCCC | 41.44 | 30108239 | |
104 | Phosphorylation | SRTETDLSFKKGERL CCCCEECCCCCCCCE | 37.52 | 30108239 | |
106 | Ubiquitination | TETDLSFKKGERLQI CCEECCCCCCCCEEE | 57.39 | 33845483 | |
180 | Phosphorylation | GTFLVRESETTKGAY CCEEEECCCCCCCEE | 29.67 | 28060719 | |
182 | Phosphorylation | FLVRESETTKGAYCL EEEECCCCCCCEEEE | 42.99 | 28060719 | |
183 | Phosphorylation | LVRESETTKGAYCLS EEECCCCCCCEEEEE | 24.35 | 28060719 | |
184 | Ubiquitination | VRESETTKGAYCLSV EECCCCCCCEEEEEH | 49.30 | 33845483 | |
187 | Phosphorylation | SETTKGAYCLSVSDF CCCCCCEEEEEHHHC | 11.55 | 28152594 | |
190 | Phosphorylation | TKGAYCLSVSDFDNA CCCEEEEEHHHCCCC | 18.93 | 28060719 | |
203 | Acetylation | NAKGLNVKHYKIRKL CCCCCCCCEEEEEEC | 39.89 | 25953088 | |
212 | Phosphorylation | YKIRKLDSGGFYITS EEEEECCCCCEEEEE | 51.78 | 28060719 | |
216 | Phosphorylation | KLDSGGFYITSRTQF ECCCCCEEEEEHHHC | 13.43 | 14760089 | |
218 | Phosphorylation | DSGGFYITSRTQFNS CCCCEEEEEHHHCCC | 10.77 | 28060719 | |
219 | Phosphorylation | SGGFYITSRTQFNSL CCCEEEEEHHHCCCH | 24.62 | 28060719 | |
246 | Phosphorylation | GLCHRLTTVCPTSKP CHHHEEEEECCCCCC | 25.38 | - | |
250 | Phosphorylation | RLTTVCPTSKPQTQG EEEEECCCCCCCCCC | 44.23 | - | |
252 | Ubiquitination | TTVCPTSKPQTQGLA EEECCCCCCCCCCCC | 43.56 | 33845483 | |
255 | Phosphorylation | CPTSKPQTQGLAKDA CCCCCCCCCCCCCCH | 32.88 | 20860994 | |
269 | Phosphorylation | AWEIPRESLRLEVKL HHHCCHHHHHEEEEE | 21.77 | 30266825 | |
298 | Ubiquitination | GTTRVAIKTLKPGTM CCEEEEEEEECCCCC | 37.76 | PubMed | |
304 | Phosphorylation | IKTLKPGTMSPEAFL EEEECCCCCCHHHHH | 24.01 | 20068231 | |
306 | Phosphorylation | TLKPGTMSPEAFLQE EECCCCCCHHHHHHH | 21.30 | 20068231 | |
338 | Phosphorylation | VVSEEPIYIVTEYMS EECCCCEEEEEEECC | 10.47 | 7578094 | |
348 | Phosphorylation | TEYMSKGSLLDFLKG EEECCCCCHHHHHHC | 29.51 | 27251275 | |
375 | Phosphorylation | DMAAQIASGMAYVER HHHHHHHHCCHHHHH | 30.63 | 22210691 | |
379 | Phosphorylation | QIASGMAYVERMNYV HHHHCCHHHHHHHHH | 8.24 | 22210691 | |
385 | Phosphorylation | AYVERMNYVHRDLRA HHHHHHHHHCHHHHH | 6.57 | 20071362 | |
404 | Ubiquitination | VGENLVCKVADFGLA ECCCEEEEEHHHHHH | 32.74 | 33845483 | |
419 | Phosphorylation | RLIEDNEYTARQGAK HHHCCCCCCCCCCCC | 16.38 | 19664994 | |
420 | Phosphorylation | LIEDNEYTARQGAKF HHCCCCCCCCCCCCC | 14.80 | 29255136 | |
426 | Ubiquitination | YTARQGAKFPIKWTA CCCCCCCCCCCEECC | 59.50 | 22817900 | |
426 | Acetylation | YTARQGAKFPIKWTA CCCCCCCCCCCEECC | 59.50 | - | |
430 | Ubiquitination | QGAKFPIKWTAPEAA CCCCCCCEECCCCHH | 38.44 | 21890473 | |
430 | Acetylation | QGAKFPIKWTAPEAA CCCCCCCEECCCCHH | 38.44 | - | |
430 (in isoform 1) | Ubiquitination | - | 38.44 | 21890473 | |
432 | Ubiquitination | AKFPIKWTAPEAALY CCCCCEECCCCHHHH | 27.60 | 22817900 | |
436 (in isoform 2) | Ubiquitination | - | 11.16 | 21890473 | |
436 | Ubiquitination | IKWTAPEAALYGRFT CEECCCCHHHHCCEE | 11.16 | 21890473 | |
439 | Phosphorylation | TAPEAALYGRFTIKS CCCCHHHHCCEEEEH | 11.09 | 27273156 | |
443 | Phosphorylation | AALYGRFTIKSDVWS HHHHCCEEEEHHHHH | 26.57 | 24505115 | |
511 | Phosphorylation | KEPEERPTFEYLQAF CCCCCCCHHHHHHHH | 35.01 | 7929427 | |
522 | Phosphorylation | LQAFLEDYFTSTEPQ HHHHHHHHHCCCCCC | 10.20 | 7929427 | |
524 | Phosphorylation | AFLEDYFTSTEPQYQ HHHHHHHCCCCCCCC | 28.63 | 26074081 | |
525 | Phosphorylation | FLEDYFTSTEPQYQP HHHHHHCCCCCCCCC | 22.37 | 26356563 | |
526 | Phosphorylation | LEDYFTSTEPQYQPG HHHHHCCCCCCCCCC | 48.94 | 26356563 | |
530 | Phosphorylation | FTSTEPQYQPGENL- HCCCCCCCCCCCCC- | 27.65 | 17449913 | |
536 (in isoform 2) | Phosphorylation | - | 6.90 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
12 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
12 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
17 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
17 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
17 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
39 | S | Phosphorylation | Kinase | PIK3CG | P48736 | PSP |
51 | S | Phosphorylation | Kinase | CHK1 | O14757 | PSP |
70 | S | Phosphorylation | Kinase | PIK3CG | P48736 | PSP |
75 | S | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
75 | S | Phosphorylation | Kinase | CDK5 | Q00535 | Uniprot |
75 | S | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
216 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
216 | Y | Phosphorylation | Kinase | SRC | P12931 | GPS |
338 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
338 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
419 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
419 | Y | Phosphorylation | Kinase | AXL | P30530 | PSP |
419 | Y | Phosphorylation | Kinase | SRC | P05480 | PSP |
419 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
419 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
419 | Y | Phosphorylation | Kinase | PDGFRA | P16234 | PSP |
419 | Y | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
419 | Y | Phosphorylation | Kinase | FAK2 | Q14289 | Uniprot |
419 | Y | Phosphorylation | Kinase | CSK | P41240 | PSP |
419 | Y | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
530 | Y | Phosphorylation | Kinase | SRC | Q9WUD9 | PSP |
530 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
530 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
530 | Y | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | STUB1 | Q9UNE7 | PMID:21911421 |
- | K | Ubiquitination | E3 ubiquitin ligase | CBLC | Q9ULV8 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | CBLB | Q13191 | PMID:12907674 |
- | K | Ubiquitination | E3 ubiquitin ligase | CBL | P22681 | PMID:10514377 |
- | K | Ubiquitination | E3 ubiquitin ligase | LNX1 | Q8TBB1 | PMID:17936276 |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:12907674 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SRC_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
D03252 | Bosutinib (USAN) | |||||
D03658 | Dasatinib (INN) | |||||
D06414 | Dasatinib hydrate (JAN); Dasatinib (USAN); Sprycel (TN) | |||||
D09664 | Saracatinib (USAN/INN) | |||||
D09665 | Saracatinib difumarate (USAN) | |||||
D09728 | Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) | |||||
D10423 | Ilorasertib (USAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Cdk5 targets active Src for ubiquitin-dependent degradation byphosphorylating Src(S75)."; Pan Q., Qiao F., Gao C., Norman B., Optican L., Zelenka P.S.; Cell. Mol. Life Sci. 68:3425-3436(2011). Cited for: PHOSPHORYLATION AT SER-75. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-35; SER-69;THR-74; SER-75; THR-511; TYR-522 AND TYR-530, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; THR-74 AND TYR-419,AND MASS SPECTROMETRY. | |
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-69; SER-75 ANDTYR-419, AND MASS SPECTROMETRY. | |
"New role for the protein tyrosine phosphatase DEP-1 in Akt activationand endothelial cell survival."; Chabot C., Spring K., Gratton J.P., Elchebly M., Royal I.; Mol. Cell. Biol. 29:241-253(2009). Cited for: PHOSPHORYLATION AT TYR-419, AND DEPHOSPHORYLATION BY PTPRJ AT TYR-419. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-530, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-439, AND MASSSPECTROMETRY. | |
"Association of the amino-terminal half of c-Src with focal adhesionsalters their properties and is regulated by phosphorylation oftyrosine 527."; Kaplan K.B., Bibbins K.B., Swedlow J.R., Arnaud M., Morgan D.O.,Varmus H.E.; EMBO J. 13:4745-4756(1994). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT TYR-530. | |
"Characterization of sites for tyrosine phosphorylation in thetransforming protein of Rous sarcoma virus (pp60v-src) and its normalcellular homologue (pp60c-src)."; Smart J.E., Oppermann H., Czernilofsky A.P., Purchio A.F.,Erikson R.L., Bishop J.M.; Proc. Natl. Acad. Sci. U.S.A. 78:6013-6017(1981). Cited for: PHOSPHORYLATION AT TYR-419. |